Tarsus Pharmaceuticals In... (TARS)
NASDAQ: TARS
· Real-Time Price · USD
54.19
0.05 (0.09%)
At close: Aug 15, 2025, 3:59 PM
54.49
0.56%
After-hours: Aug 15, 2025, 06:30 PM EDT
Tarsus Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 96.65M | 175.79M | 94.82M | 176.21M | 181.09M | 193.71M | 224.95M | 226.67M | 106.77M | 66M | 71.66M | 169.49M | 245.36M | 175.01M | 171.33M | 183.8M | 176.74M | 156.18M |
Short-Term Investments | 284.5M | 232.13M | 196.56M | 140.74M | 142.49M | 104.82M | 2.5M | 20.21M | 71.45M | 135.22M | 145.37M | 57.08M | n/a | 291K | 483K | n/a | n/a | n/a |
Long-Term Investments | 5.56M | 3M | 3M | 3M | 3M | n/a | 631K | 210K | 322K | 306K | 371K | 157K | 169K | n/a | -482.52K | n/a | n/a | n/a |
Other Long-Term Assets | 3.75M | 5.71M | 6.09M | 3.42M | 3.38M | 1.32M | 1.51M | 1.25M | 1.45M | 529K | 585K | 583K | 600K | 887K | 1.61M | 1.61M | 1.52M | 1.33M |
Receivables | 60.24M | 64.15M | 48.06M | 30.3M | 30.84M | 31.36M | 17.71M | 6.37M | 246K | 2.92M | 3.58M | 4.01M | 620K | 323K | 92K | 139K | 20.16M | 32.2M |
Inventory | 3.87M | 2.71M | 2.62M | 2.85M | 2.19M | 4.04M | 3.11M | 15K | n/a | -418K | n/a | -4M | n/a | n/a | 4.13M | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.01M | 5M | n/a | n/a | n/a | 4.3M | 3.13M | n/a | 3.15M | 4.01M | 267K |
Total Current Assets | 474.43M | 480.77M | 356.7M | 357.12M | 362.59M | 340.72M | 256.13M | 259.28M | 183.48M | 208.65M | 225.38M | 234.08M | 250.28M | 178.75M | 175.95M | 187.09M | 200.9M | 191.45M |
Property-Plant & Equipment | 3.41M | 3.18M | 2.87M | 4.2M | 4.21M | 3.47M | 3.35M | 3.63M | 3.68M | 1.73M | 1.53M | 1.65M | 1.78M | 1.84M | 1.83M | 1.71M | 1.02M | 1.17M |
Goodwill & Intangibles | 7.85M | 8.09M | 8.33M | 8.57M | 3.67M | 3.77M | 3.87M | 3.97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 20.57M | 19.98M | 20.29M | 19.18M | 14.26M | 8.55M | 10.09M | 9.05M | 5.45M | 2.57M | 2.49M | 2.39M | 2.54M | 2.73M | 2.96M | 3.32M | 2.55M | 2.5M |
Total Assets | 494.99M | 500.75M | 376.99M | 376.3M | 376.84M | 349.28M | 266.22M | 268.33M | 188.93M | 211.21M | 227.86M | 236.47M | 252.83M | 181.48M | 178.91M | 190.41M | 203.45M | 193.95M |
Account Payables | 28.07M | n/a | 27.74M | 26.82M | 26.65M | 19.14M | 18.15M | 10.38M | 8.17M | 7.57M | 5.5M | 5.59M | 4.09M | 3.97M | 2.86M | 2.01M | 3.3M | 5M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10.8M | -8.6M | n/a | n/a | -572K | n/a | n/a | -4.16M | n/a | 342K | 313K |
Short-Term Debt | 317K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 50.25M | 43.69M | 36.44M | n/a | n/a | 16.84M | 5.14M | 4.55M | n/a | 766K | 3.69M | 4M | n/a | 5.97M | 55K | 4.54M | 342K | 313K |
Total Current Liabilities | 90.25M | 86.31M | 80.61M | 65.87M | 51.57M | 42.53M | 36.94M | 23.25M | 14.77M | 13.26M | 15.43M | 14.27M | 11.72M | 12.61M | 11.48M | 10.37M | 10.46M | 10.12M |
Long-Term Debt | 72.13M | 71.98M | 71.84M | 71.71M | 71.58M | 29.93M | 29.82M | 29.71M | 24.61M | 24.52M | 19.43M | 19.36M | 19.26M | 19.18M | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | 1.24M | 1.45M | 1.61M | 233K | 1.71M | 1.83M | 40K | 100K | 40K | 43K | 71K | 114K | 150K | 119K | 148K |
Total Long-Term Liabilities | 72.13M | 71.98M | 71.84M | 72.95M | 73.03M | 31.54M | 32.3M | 31.42M | 26.43M | 24.55M | 19.53M | 19.57M | 19.61M | 19.68M | 699K | 905K | 524K | 604K |
Total Liabilities | 162.38M | 158.29M | 152.46M | 138.82M | 124.6M | 74.07M | 69.24M | 54.67M | 41.2M | 37.81M | 34.96M | 33.84M | 31.32M | 32.29M | 12.18M | 11.27M | 10.98M | 10.72M |
Total Debt | 72.45M | 72.37M | 72.45M | 72.34M | 72.18M | 30.52M | 31.73M | 30.13M | 25.04M | 24.52M | 20.16M | 20.1M | 20.17M | 20.41M | 1.89M | 2.33M | 2.14M | 677K |
Common Stock | 6K | 6K | 6K | 6K | 6K | 6K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 4K | 4K | 4K | 4K | 4K |
Retained Earnings | -405.67M | -385.33M | -360.21M | -337.1M | -313.68M | -280.39M | -244.66M | -202.75M | -163.61M | -132.18M | -108.76M | -95.16M | -72.65M | -66.91M | -46.67M | -31.82M | -16.12M | -22.47M |
Comprehensive Income | 39K | 85K | 179K | 346K | -176K | -63K | -2K | -8K | -23K | -70K | -74K | -10K | -0.00 | n/a | n/a | n/a | -266K | -142K |
Shareholders Equity | 332.61M | 342.46M | 224.53M | 237.48M | 252.25M | 275.21M | 196.99M | 213.66M | 147.73M | 173.4M | 192.9M | 202.63M | 221.5M | 149.2M | 166.73M | 179.14M | 192.47M | 183.23M |
Total Investments | 290.06M | 235.13M | 199.56M | 143.74M | 145.49M | 104.82M | 3.13M | 20.42M | 71.78M | 135.53M | 145.74M | 57.49M | 169K | 291K | 483.00 | n/a | n/a | n/a |